Europe — EMA
Xenetix (Iobitridol)
Xenetix (Iobitridol) is a non-ionic, low-osmolar contrast agent used in medical imaging. It enhances visibility of blood vessels and tissues during procedures.
Request sourcing
What is Iobitridol?
Xenetix (Iobitridol) is a non-ionic, low-osmolar contrast agent used in medical imaging. It enhances visibility of blood vessels and tissues during procedures. Suitable for intraarterial and intravenous imaging. Contrast agent for ct scans mri and angiography.
What is Iobitridol used for?
Xenetix (Iobitridol) is primarily used as a contrast agent to improve the visibility of blood vessels, organs, and tissues during imaging procedures. It is commonly employed in CT scans, MRIs, and angiographic studies to highlight vascular structures and detect abnormalities. This agent helps radiologists and physicians obtain clearer images for accurate diagnosis.
What are the side effects of Iobitridol?
Xenetix (Iobitridol) works by temporarily increasing the contrast between different tissues in the body, making it easier to distinguish between them on imaging scans. Patients may experience a warm sensation or metallic taste during administration, which is normal and temporary. The effects typically resolve shortly after the imaging procedure is completed.
What precautions apply to Iobitridol?
Xenetix (Iobitridol) should be used with caution in patients with known allergies to iodine or contrast agents. Adequate hydration before and after administration is recommended to reduce the risk of kidney-related side effects. Patients with severe kidney disease or a history of reactions to contrast media should inform their healthcare provider prior to use.
What does Iobitridol interact with?
Xenetix (Iobitridol) may interact with medications that affect kidney function, such as certain diuretics or nephrotoxic drugs. Concurrent use of metformin in patients with kidney impairment may increase the risk of lactic acidosis; temporary discontinuation of metformin may be advised. Always disclose all medications to your healthcare provider before receiving this contrast agent.



